<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 09 Nov 2009 07:22:53 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Stocks End Broadly, But Modestly, In Red</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3379186</guid>
      <description><![CDATA[Stocks close modestly lower, with all major averages down 0.3%-0.4% and ending well off session lows after a late-day rally. Wall Street absorbed mixed economic and earnings reports and remains hestitant to extend the recent rally<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3379186>[More...]</a>]]></description>
      <pubDate>Wed, 29 Jul 2009 20:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BARE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ELRN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FISV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MGM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">S</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YHOO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3379186</link>
    </item>
    <item>
      <title>Fundamentals vs Technical</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3006165</guid>
      <description><![CDATA[Do you watch Jim Cramer on Mad Money? Do you follow his recommendations on what to buy and sell? If so, how are those recommended stocks are doing?    Gurus like Jim Cramer and Suz Orman are often seen on TV offering their advices to audiences on where to invest their money or how to handle their personal finance, but often times what they offered are only proven to be wrong later. In the February 2009 issue of&#160; Kiplinger’s Personal Finance magazine, there’s an article on what the gurus said then and what really happened later. The paragraph about Jim Cramer is like this:    HE SAID “The market will no revisit the panicked lows it hit on July 15 … Bye-bye, bear market. Say hello to the bull,<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3006165>[More...]</a>]]></description>
      <pubDate>Tue, 03 Feb 2009 17:03:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VZ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3006165</link>
    </item>
    <item>
      <title>Newalta, New Dividend Kid On The Block</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2769845</guid>
      <description><![CDATA[Canada's leading industrial waste management and environmental services company, Newalta currently (NAL.UN) has announced it is converting to a corporation. Newalta plans to eventually pay a quarterly dividend of $0.20/quarter (eligible dividends), this represents a yield of 8.9% on Tuesdays closing price.  Newalta also announced a 5% rise in earnings per share and that they are cutting their cap ex growth budget by 30% for 2009. Half of Newalta's growth as a company to date has been through about 50 successful acquisitions.  Here are some highlights of Newalta's distribution history March 2003 Monthly distributions initially set at 9.0&#162; per unit at conversion Sept 2003 Distributions were increased to 10.5&#162;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2769845>[More...]</a>]]></description>
      <pubDate>Wed, 05 Nov 2008 15:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EVRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2769845</link>
    </item>
    <item>
      <title>Europe Apparently has Money</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2480153</guid>
      <description><![CDATA[As most of you probably know, I am a huge basketball fan. For decades now, athletes have made millions playing the silly game. For many, the dream was to become a NBA star; however, that as all seemed to change now.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2480153>[More...]</a>]]></description>
      <pubDate>Wed, 06 Aug 2008 05:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MLS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2480153</link>
    </item>
    <item>
      <title>Just 18 Stocks To Watch Today!</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2271781</guid>
      <description><![CDATA[AAPL oh my god 3G is coming..developers conference…blehhhh..STFU you friggin geeks, I covered this stock last week, nothing’s changed<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2271781>[More...]</a>]]></description>
      <pubDate>Mon, 09 Jun 2008 15:40:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AAPL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNEH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CYPW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">END</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HYHY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LBAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NCEY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PARD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PARL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PCYC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PTEK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UTSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2271781</link>
    </item>
    <item>
      <title>Announcing INO TV in Detail</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1742546</guid>
      <description><![CDATA[Now you can view trading seminars from the comfort of your home, or in the office or anywhere else there is a high-speed internet connection.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1742546>[More...]</a>]]></description>
      <pubDate>Tue, 22 Apr 2008 19:11:13 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1742546</link>
    </item>
    <item>
      <title>A Brief Look at Financials</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1683716</guid>
      <description><![CDATA[The Financials Sector (XLF) has received considerable attention as of late, but let’s look at the chart for a few more insights:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1683716>[More...]</a>]]></description>
      <pubDate>Wed, 02 Apr 2008 15:24:26 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XLF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1683716</link>
    </item>
    <item>
      <title>Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration Agreement to Develop Universal Influenza Vaccines</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3403649</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today it has entered into a research collaboration agreement with the National Institutes of Health (NIH)’s Vaccine Research Center (VRC) to develop influenza vaccines. Under the agreement, the VRC and Inovio will pool technologies to develop universal influenza vaccines as well as rapidly advance development of vaccine candidates targeting the emerging pandemic 2009 H1N1 swine flu strains.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3403649>[More...]</a>]]></description>
      <pubDate>Mon, 10 Aug 2009 06:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3403649</link>
    </item>
    <item>
      <title>First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3394003</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today new data representing what Inovio believes to be the first demonstration of a significantly increased and persistent level of antibody response generated by a DNA vaccine delivered using electroporation.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3394003>[More...]</a>]]></description>
      <pubDate>Wed, 05 Aug 2009 06:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3394003</link>
    </item>
    <item>
      <title>Inovio Closes $30 Million Registered Direct Offering</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3386452</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”), a leader in DNA vaccine design, development and delivery, announced today the closing of the sale, directly to institutional investors, of 11,111,110 shares of its common stock and warrants to purchase up to 2,777,776 additional shares of its common stock, resulting in cash proceeds to Inovio Biomedical of approximately $30 million. Inovio expects to receive net proceeds of approximately $28.5 million after deducting placement agent fees and other offering expenses. Each unit, consisting of one share of common stock and a warrant to purchase approximately 0.25 of a share of common stock, was sold for a purchase price of $2.70. The warrants to purchase additional shares will be exercisable at an exercise price of $3.50 per share beginning six months after issuance and will expire six months from the date they are first exercisable.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3386452>[More...]</a>]]></description>
      <pubDate>Fri, 31 Jul 2009 17:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3386452</link>
    </item>
    <item>
      <title>Inovio Announces $30 Million Registered Direct Offering</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3382173</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”), a leader in DNA vaccine design, development and delivery, announced today that it has received commitments from institutional investors to purchase $30 million of securities in a registered direct offering. Inovio expects to receive net proceeds of approximately $28.5 million after deducting placement agent fees and other offering expenses. Under the terms of a Securities Purchase Agreement, Inovio will sell an aggregate of 11,111,110 shares of its common stock and warrants to purchase up to 2,777,776 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase approximately 0.25 of a share of common stock, will be sold for a purchase price of $2.70.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3382173>[More...]</a>]]></description>
      <pubDate>Thu, 30 Jul 2009 11:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RODM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3382173</link>
    </item>
    <item>
      <title>Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3378263</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ H1N1 influenza DNA vaccines achieved protection against current circulating swine origin influenza A/H1N1 viruses in animal studies.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3378263>[More...]</a>]]></description>
      <pubDate>Wed, 29 Jul 2009 09:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3378263</link>
    </item>
    <item>
      <title>Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3373352</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company's first SynCon™ dengue virus DNA vaccine induced neutralizing antibody responses against all four distinct serotypes of dengue viruses that are transmitted to humans by mosquitoes. Currently there is no commercially available vaccine or antiviral drug against dengue virus infections. The results were published in Vaccine, July 3, 2009, in a paper entitled, “Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes” (Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3373352>[More...]</a>]]></description>
      <pubDate>Mon, 27 Jul 2009 09:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3373352</link>
    </item>
    <item>
      <title>Inovio Biomedical to Present at Jesup &amp; Lamont Growth Stock Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3373347</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that the company's CEO, Dr. J. Joseph Kim, will present at Jesup &amp; Lamont’s 2009 Growth Stock &amp; National Sales Conference to be held at the Waldorf Astoria Boca Beach Club on July 30th in Boca Raton, Florida.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3373347>[More...]</a>]]></description>
      <pubDate>Mon, 27 Jul 2009 09:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3373347</link>
    </item>
    <item>
      <title>Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3344596</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ H1N1 influenza DNA vaccines achieved protective antibody responses against H1N1 swine influenza virus (A/Swine/Iowa/35233/1999) in 100% of pigs immunized with a two-dose vaccine regimen.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3344596>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 04:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3344596</link>
    </item>
    <item>
      <title>Inovio Biomedical to Present at International DNA Vaccine Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3332140</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it will make multiple presentations at the Annual Conference of DNA Vaccines in Asia 2009 being hosted by the International Society of DNA Vaccines July 9 – 10 at the Beijing International Convention Center. The conference, with the theme, “Advancing DNA Vaccine Technology,” is co-chaired by David B. Weiner, Ph.D., professor of pathology, University of Pennsylvania School of Medicine, and chairman of Inovio’s scientific advisory board.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3332140>[More...]</a>]]></description>
      <pubDate>Mon, 06 Jul 2009 06:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3332140</link>
    </item>
    <item>
      <title>Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against “Swine” Influenza A (H1N1)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3321130</guid>
      <description><![CDATA[Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it has established a new collaboration with the National Microbiology Laboratory of the Public Health Agency of Canada and the University of Pennsylvania to further evaluate Inovio DNA vaccine candidates against swine influenza A (H1N1) virus. As a part of its universal influenza vaccine program, Inovio has designed and manufactured consensus DNA vaccines for H1N1 influenza strains. These consensus vaccines, delivered using Inovio’s proprietary electroporation technology, have the potential to provide protection against a broad scope of existing as well as currently unknown, unmatched influenza strains that could emerge -- one of the perpetual challenges in trying to protect against influenza. The purpose of this collaboration is to test these vaccine candidates against pandemic and seasonal influenza strains in animal models and will include testing against a recently identified swine H1N1 strain.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3321130>[More...]</a>]]></description>
      <pubDate>Tue, 30 Jun 2009 06:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3321130</link>
    </item>
    <item>
      <title>Form  4          Williams David J          For: Oct 26 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591889</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591889>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 00:26:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591889</link>
    </item>
    <item>
      <title>Form  3          Williams David J          For: Oct 26 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591888</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591888>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 00:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591888</link>
    </item>
    <item>
      <title>Form  4          COLLINS MORTON            For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525275</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525275>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525275</link>
    </item>
    <item>
      <title>Form  4          NG TEE KHIANG             For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525277</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525277>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525277</link>
    </item>
    <item>
      <title>Form  4          BENITO SIMON X            For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525278</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525278>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525278</link>
    </item>
    <item>
      <title>Form  4          Rassas Kevin              For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525279</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525279>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525279</link>
    </item>
    <item>
      <title>Form  4          Sardesai Niranjan         For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525281</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525281>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525281</link>
    </item>
    <item>
      <title>Form  4          Kim Jong Joseph           For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525272</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525272>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525272</link>
    </item>
    <item>
      <title>Form  4          KIES PETER                For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525274</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525274>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525274</link>
    </item>
    <item>
      <title>Form  4          Fons Michael              For: Sep 30 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525270</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525270>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 23:40:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525270</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=INO" rel="self" type="application/rss+xml" />
  </channel>
</rss>